Approval · Notice of Compliance 21997 · 2018
VERMOX: Notice of Compliance 21997
Issued March 21, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21997
- Date
- March 21, 2018
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the product monograph by removing recommendation for repeat treatment
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VERMOX | Not yet assigned | — |
Medicinal ingredients
- MEBENDAZOLE 100 MG per TAB